Section I
61 – 70 of 4892
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Stereotactic Body Radiotherapy as Metastasis-Directed Therapy in Oligometastatic Prostate Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - Beyond the Abstract
2025)(
- Other contribution › Web publication
-
Mark
Metabolic syndrome is associated with breast cancer mortality : A systematic review and meta-analysis
(
- Contribution to journal › Article
-
Mark
Reply to Laila Schneidewind, Fabian P. Stangl, Jennifer Kranz, and Gernot Bonkat's Letter to Editor re : Fredrik Liedberg, Evanguelos Xylinas, Paolo Gontero. Quinolone Prophylaxis in Conjunction with Bacillus Calmette-Guérin Instillations for Bladder Cancer: Time To Reconsider the Evidence and Open the Quinolone Box? Eur Urol Focus 2024;10:564–6
2025) In European Urology Focus(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
(
- Contribution to journal › Article
-
Mark
The DNA methylation landscape of primary triple-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Experiences of rehabilitation one year after breast cancer diagnosis-A focus group study from the ReScreen randomized controlled trial
(
- Contribution to journal › Article
-
Mark
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma
(
- Contribution to journal › Article
-
Mark
Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy
(
- Contribution to journal › Article
-
Mark
Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund Center
(
- Contribution to journal › Scientific review
-
Mark
PUS10-induced tRNA fragmentation impacts retrotransposon-driven inflammation
(
- Contribution to journal › Article